Loading...
Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death
On December 16, 2015, the Food and Drug Administration (FDA) in the United States approved sugammadex (Bridion, Merck and Co), a modified gamma-cyclodextrin, to be used as a reversal agent. It is a first and unique selective nondepolarizing steroidal muscle relaxant (NDSMR) binding agent with a grea...
Na minha lista:
| Udgivet i: | Case Rep Anesthesiol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7303763/ https://ncbi.nlm.nih.gov/pubmed/32566314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8767195 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|